For those aspiring to work in financial IT, IT consulting, or the FinTech sector, these two companies are often compared. However, simply grouping them together as "companies strong in financial IT" ...
Lead candidate BM-3103 (TolaSure® Gel™) now holds Fast Track, Orphan Drug, and Rare Pediatric Disease designations as BioMendics advances the TAMES-02 Phase 2 study (NCT07027345). AKRON, ...
When Ben Rosenfeld started working as a residential assistant at a Stanford University dorm, he encountered 77 freshmen possessed by an “all-consuming” force. His new gig coincided with the release of ...
ROOTSTOWN, Ohio--(BUSINESS WIRE)--#Biotech--As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing ...
The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...
One day in November, a product strategist we’ll call Michelle (not her real name), logged into her LinkedIn account and switched her gender to male. She also changed her name to Michael, she told ...
The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...
ROOTSTOWN, Ohio--(BUSINESS WIRE)--#BioMendics--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a ...
Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short—may have a key role in the development of Alzheimer's disease, suggests a large US ...
People store large quantities of data in their electronic devices and transfer some of this data to others, whether for professional or personal reasons. Data compression methods are thus of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results